top of page
SURGIGRAFT-LOGO_CS6.jpg

surgiGRAFT Product Attributes

 

The surgiGRAFT suite of products includes amniotic tissue derived allografts intended for reconstruction, repair, or replacement of a patient’s tissue.

 

Chorion free and orientation neutral Hydrated Form: hydrophilic properties allow tissue to conform to the surface or surgical site

 

Dry Form: handling properties allow easy application for open surgical techniques

 

Ambient temperature storage: terminally sterilized with up to a 3-year shelf life

 

Flexible: naturally conforms to complex anatomies

 

Fully resorbable: may be applied directly over bone, tendon, nerves, and wounds

Available in a range of sizes for optimal coverage.

coding flyer 1.png
DRY GRAFTS.png
coding flyer 4.png

For reimbursement support, please email reimbursement@synergybiologics.net

Amniotic Tissue Allografts are regulated under the FDA’s Public Health Service Act Section 361 as a Human Cell, Tissue or Cellular or Tissue Based Product (HCTP).

 

Handled according to all FDA regulations for Current Good Tissue Practices, its manipulation and processing are kept to a minimum, ensuring the preservation of its innate properties that help to promote advanced healing.

FDA Tissue standards pic_edited_edited.png

FDA Tissue Standards 

bottom of page